The role of SWI/SNF disruption in thyroid cancer progression has been investigated in transgenic mice with co-mutation of SWI/SNF genes and HRAS p.G12V or BRAF p.V600E, highlighting the cooperative role of SWI/SNF in promoting loss of differentiation and tumor progression (176, 177). Here, HRAS is linked to neoplasm.